Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Related News

02-Sep-2019 08:50 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1645p (from 1620p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Aug-2019 09:00 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today initiates coverage of GlaxoSmithKline PLC (LON:GSK) with a neutral investment rating and price target of 1700p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Jul-2019 12:40 PM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1620p (from 1575p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-Jul-2019 01:10 PM

GlaxoSmithKline upgrades guidance amid bumper shingles vaccine sales

Pharmaceutical company GlaxoSmithKline upgraded its annual earnings guidance after sales rose 7% in the second quarter. The company also announced that John Symonds, the current deputy chairman of lender HSBC, had been appointed as its new chairman to re
23-Jul-2019 10:10 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1610p (from 1630p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
08-Jul-2019 09:20 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1575p (from 1550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
21-Jun-2019 04:30 PM

FTSE 100 under the weather as pharma stocks turn sickly

The FTSE 100 endured a downbeat end to the week, falling more than 0.5% as the pharmaceutical sector came under some pressure. GlaxoSmithKline fell 1.3%, AstraZeneca was down 2% and Reckitt Benckiser slipped 1.8% on the threat of US government interventi
17-Jun-2019 12:50 PM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today initiates coverage of GlaxoSmithKline PLC (LON:GSK) with a underweight investment rating and price target of 1520p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Jun-2019 11:10 AM

Broker Forecast - Kepler Cheuvreux issues a broker note on GlaxoSmithKline PLC

Kepler Cheuvreux today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1540p (from 1440p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-May-2019 08:20 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1550p (from 1520p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2019 12:10 PM

Broker Forecast - Bryan Garnier issues a broker note on GlaxoSmithKline PLC

Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1660p (from 1710p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2019 01:19 PM

GlaxoSmithKline earnings bolstered by shingles vaccine, HIV treatment

Pharmaceuticals giant GlaxoSmithKline posted a rise in first-quarter earnings and reaffirmed its annual guidance following strong sales of its shingles vaccine and HIV treatments. Earnings per share for the three months through March rose 50% to 16.8p, o
08-Mar-2019 08:50 AM

Broker Forecast - Shore Capital issues a broker note on GlaxoSmithKline PLC

Shore Capital today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to hold (from buy). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Feb-2019 10:30 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to neutral (from buy) and cut its price target to 1650p (from 1700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
07-Feb-2019 10:50 AM

Broker Forecast - HSBC issues a broker note on GlaxoSmithKline PLC

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1860p (from 1820p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Feb-2019 01:12 PM

GlaxoSmithKline annual profit rises 36%; warns of earnings decline in 2019

GlaxoSmithKline posted a 36% rise in pre-tax profit, underpinned higher sales of its shingles vaccine and respiratory disease treatments, but warned of lower earnings in 2019. Pre-tax profit for the year through December rose to £4.80bn, as sales c
21-Jan-2019 07:42 AM

GlaxoSmithKline chairman Philip Hampton to step down

GlaxoSmithKline said chairman Philip Hampton would stand down following the pharmaceutical company's decision to separate out its consumer health business. A search for Hampton's successor was underway. GlaxoSmithKline announced in December th
11-Dec-2018 08:40 AM

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1750p (from 1725p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-Dec-2018 08:50 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1520p (from 1525p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
05-Dec-2018 10:30 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to equal weight (from overweight). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
28-Nov-2018 08:10 AM

Broker Forecast - HSBC issues a broker note on GlaxoSmithKline PLC

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2000p (from 2030p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Oct-2018 01:21 PM

GlaxoSmithKline lifts guidance after strong shingles vaccine sales

GlaxoSmithKline slightly upgraded its annual guidance after bumper sales of its shingles vaccine Shingrix helped it boost third-quarter operating profit by 2%. Operating profit for the three months through September rose to £1.91bn, as revenue rose
07-Sep-2018 12:40 PM

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1725p (from 1775p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Sep-2018 09:30 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price target at 1525p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Aug-2018 08:10 AM

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Liberum Capital today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to hold (from buy) and raised its price target to 1700p (from 1630p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t